Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TRITAX BIG BOX REIT PLC. We currently have 2 research reports from 2 professional analysts.
|28Mar17 11:29||RNS||Notice of AGM|
|07Mar17 07:00||RNS||FULL YEAR RESULTS|
|07Mar17 07:00||RNS||Dividend Declaration|
|01Mar17 07:00||RNS||New Fixed Rate Term Loan Facility of £90 Million|
|22Feb17 07:00||RNS||Forward funded investment|
|07Feb17 07:00||RNS||Notice of Results|
|19Jan17 07:00||RNS||Trading Statement|
Frequency of research reports
Research reports on
TRITAX BIG BOX REIT PLC
TRITAX BIG BOX REIT PLC
Listed Real Estate
20 May 16
There are suggestions that the sector has peaked, but we feel this relates more to Central London than the rest of the country: the EU referendum has certainly provided an excuse to ‘wait and see’, compounding the effect of any uncertainty. Activity levels have suffered and the growth momentum slowed, and this is now showing up clearly in market data. However, the impact is not universal and is concentrated on the more exposed investment areas of Central London, leaving bright spots across the sector for investors to exploit.
Debt & renewables dominate
09 Jan 14
A total of £3.1bn was raised in the funds sector in the fourth quarter of 2013, exceeding total funds raised for the whole of 2012 (£2.7bn). The alternative asset and income theme continued to dominate, with most successful vehicles offering yields in excess of 5%.
28 Mar 17
ClearStar* (CLSU): Building a background for growth (CORP) | Sound Energy (SOU): TE-8 results (HOLD) | LiDCO* (LID): 2017 should be a transformative year (CORP) | Proteome Sciences* (PRM): FY 2016 in line. Moving towards breakeven (CORP) | Fulcrum (FCRM): Significant market potential, rising margins and a strong balance sheet (BUY) | Mortgage Advice Bureau (MAB1): Strong and growing intellectual property (BUY) | 7digital* (7DIG): Open offer result (CORP)
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.